The policy further expands access to Luminopia's engaging, FDA-cleared treatment for children with lazy eye CAMBRIDGE, Mass., Feb. 25, 2026 /PRNewswire/ -- Luminopia, Inc., a digital health company ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Luminopia, a software system approved by the US Food and Drug Administration to treat amblyopia by modifying TV shows and movies in virtual reality (VR) headsets, is improving visual acuity for ...

A new study's findings may transform worldwide treatment for the most common childhood visual disease, and the Philadelphia area can now call one of the lead researchers a local. Amblyopia, or lazy ...

Please provide your email address to receive an email when new articles are posted on . Evidence suggests that neuroplasticity in adults may be leveraged to improve vision in amblyopia. Binocular ...

Please provide your email address to receive an email when new articles are posted on . Errors of refraction and strabismic amblyopia were the most common causes of low vision. Retinal diseases most ...

ORLANDO, Florida — Portable vision screening devices can simply and accurately identify vision problems in young children, according to a study that evaluated the sensitivity and specificity of 4 such ...

In the "ThemenCheck Medizin" procedure offered by the German Institute for Quality and Efficiency in Health Care (IQWiG), interested members of the public can submit proposals for the assessment of ...

Amblyopia, often referred to as 'lazy eye', is a neurodevelopmental disorder characterised by reduced visual acuity in the absence of overt structural defects. Advances in optical coherence tomography ...

Adults who had amblyopia (‘lazy eye’) in childhood are more likely to experience hypertension, obesity, and metabolic syndrome in adulthood, as well as an increased risk of heart attack, finds a new ...